241 results on '"Zupo, S."'
Search Results
2. A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients
3. The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma
4. Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo
5. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment
6. PD-9 Universal screening for Lynch syndrome: Reflex testing to improve appropriateness of genetic counseling and diagnosis
7. Progesterone Receptor B Recruits a Repressor Complex to a Half-PRE Site of the Estrogen Receptor α Gene Promoter
8. INK4/ARF germline alterations in pancreatic cancer patients
9. Subepithelial B Cells of the Human Tonsil
10. Normal and Neoplastic B Lymphocytes Produce Interleukin-1 (IL-1) and Colony Stimulating Factor (CSF)
11. Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression
12. A GLOBAL PROGRESSION RISK SCORE FOR EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: THE NEVER-ENDING STORY
13. CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma from Liguria
14. Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study
15. Gene expression analysis of peripheral t-cell lymphoma not otherwise specified reveals two distint subgroups and recurrent PDGFRa; deregulation
16. Gene Expression analysis of Peripheral T-Cell Lympoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Celular Counterparts and Recurrent PDGFRA Deregulation
17. A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients
18. Characterization of a novel human surface molecule selectively expressed by mature thymocytes, activated T cells and subsets of T cell lymphomas
19. Frequency and clinical correlations of epidermal growth factor receptor (EGFR) mutations in a large cohort of italian non-small-cell lung cancer (NSCLC) patients (pts) within the EGFR FASTnet program
20. Differentiation on Biological Basis of Monoclonal B-Cell Lymphocytosis (MBL) From Chronic Lymphocytic Leukemia (CLL): Results of a Prospective GISL (Gruppo Italiano Studio Linfomi) Trial
21. Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL
22. Heterogeneous expression and function ofIL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells
23. Report from the OECI Oncology days 2014
24. Report from the OECI Oncology days 2014
25. DIAGNOSTIC POTENTIAL OF CD38 COMBINED WITH ZAP70 EXPRESSION IN PREDICTING MUTATIONAL STATUS OF IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION IN CHRONIC LYMPHOCYTIC LEUKEMIA: PRELIMINARY RESULTS OF A PROSPECTIVE, MULTICENTER O-CLL1- GISL STUDY
26. INCIDENCE OF CYTOGENETIC ABNORMALITIES IN NEWLY DIAGNOSED BINET STAGE A B-CLL AND RELATIONSHIP WITH PROGNSOTIC BIOMARKERS: PRELIMINARY RESULTS ON 240 PATIENTS INCLUDED IN THE PROSPECTIVE, MULTICENTER O-CLL1 GISL STUDY
27. Different prognostic groups of B- cell chronic lymphocytic leukemia (B-CLL) patients defined by CD38 and ZAP-70 expression, IGVH gene status and gene expression profile
28. Diagnostic potential of CD38 combined with zap-70 expression in predicting mutational status of immunoglobulin heavy-chain variable region in chronic lymphocytic leukemia(cll)
29. Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization of a novel subset
30. B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP-70 determination on bone marrow biopsies
31. The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma
32. Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages
33. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma
34. Chromosome aberrations evaluated by CGH in B-cell chronic lymphocytic leukemia: correlation with CD38 expression
35. Recent views on B cell chronic lymphocytic leukemia pathophysiology
36. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Haematologica
37. Mutazioni germinali al locus INK4/ARF in pazienti affetti da adenocarcinoma pancreatico in relazione alla storia oncologica familiare
38. INK4/ARF germline mutations and additional neoplasia in pancreatic cancer patients and their families
39. Immunoglobulin V genes and CD38 expression analysis in B cell chronic lymphocytic leukemia. Blood. Letter
40. CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma from Liguria
41. CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma
42. Heterogeneity of tonsilar subepithelial B lymphocytes, the splenic marginal zone equivalents
43. CD38 EXPRESSION DISTINGUISHES TWO GROUPS OF B CELL-CHRONIC LYMPHOCYTIC LEUKEMIAS WITH DIFFERENT RESPONSE TO ANTI IgM ANTIBODIES AND PROPENSITY TO APOPTOSIS
44. Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo
45. EGFR FASTnet: The Italian network for epidermal growth factor receptors (EGFR) mutation analysis in non-small cell lung cancer (NSCLC).
46. Characterization of EN4 monoclonal antibody: a reagent with CD31 specificity
47. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells
48. Human sperm express a functional androgen receptor: effects on PI3K/AKT pathway
49. The Response to Surface IgM and IgD Cross-Linking Defines Different Groups of B-CLL.
50. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.